Compare ARDX & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | KARO |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2014 | 2020 |
| Metric | ARDX | KARO |
|---|---|---|
| Price | $5.09 | $63.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | $15.14 | ★ $59.33 |
| AVG Volume (30 Days) | ★ 3.4M | 133.7K |
| Earning Date | 04-30-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,607,000.00 | N/A |
| Revenue This Year | $37.75 | $22.17 |
| Revenue Next Year | $34.24 | $16.74 |
| P/E Ratio | ★ N/A | $24.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.08 | $41.25 |
| 52 Week High | $8.40 | $66.19 |
| Indicator | ARDX | KARO |
|---|---|---|
| Relative Strength Index (RSI) | 38.69 | 68.01 |
| Support Level | $4.95 | $43.38 |
| Resistance Level | $5.34 | $66.19 |
| Average True Range (ATR) | 0.17 | 2.83 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 21.12 | 74.04 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Karooooo Ltd is a provider of an operational intelligence platform. Through its cloud platform, the company enables fleet and asset management, fuel management, workforce management, logistics, safety, including AI-assisted video safety, compliance, risk, and environmental impact management. Its segments are: Cartrack, which generates the majority of revenue, provides an operational intelligence platform that maximizes the value of transportation, operations, and workflow data through insightful real-time data analytics to connected vehicles and equipment, and Karooooo Logistics provides a software application enabling the management of last-mile B2B delivery and general operational logistics (Delivery-as-a-Service or DaaS). It generates the majority of its revenue from South Africa.